Company News
Concord Biotech Acquires 27.38% Stake in FSGE Renewable
Concord Biotech invests ₹6.3 crore to acquire 27.38% equity in FSGE Renewable Power for captive wind-solar hybrid project.
The 6.3 MW AC wind and 6.3 MWp DC solar project will power company's Limbasi
